337 related articles for article (PubMed ID: 29595061)
1. Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.
Vesco AT; Jedraszko AM; Garza KP; Weissberg-Benchell J
J Diabetes Sci Technol; 2018 Jul; 12(4):792-799. PubMed ID: 29595061
[TBL] [Abstract][Full Text] [Related]
2. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
Telo GH; Volkening LK; Butler DA; Laffel LM
Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
[TBL] [Abstract][Full Text] [Related]
3. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
5. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
6. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
[TBL] [Abstract][Full Text] [Related]
7. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
8. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
[TBL] [Abstract][Full Text] [Related]
9. Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience.
Marigliano M; Eckert AJ; Guness PK; Herbst A; Smart CE; Witsch M; Maffeis C;
Pediatr Diabetes; 2021 Dec; 22(8):1120-1128. PubMed ID: 34716736
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
11. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
[TBL] [Abstract][Full Text] [Related]
12. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Externally Worn Diabetes Technology on Sexual Behavior and Activity, Body Image, and Anxiety in Type 1 Diabetes.
Robertson C; Lin A; Smith G; Yeung A; Strauss P; Nicholas J; Davis E; Jones T; Gibson L; Richters J; Bock M
J Diabetes Sci Technol; 2020 Mar; 14(2):303-308. PubMed ID: 31441324
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
17. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
[No Abstract] [Full Text] [Related]
18. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
Peyrot M; Rubin RR
Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
[TBL] [Abstract][Full Text] [Related]
20. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
